Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients

World Journal of Oncology - Canada
doi 10.4021/wjon2010.06.213w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elmer Press, Inc.

Related search

Activation of mTOR in a Subgroup of Ovarian Carcinomas: Correlation With P-eIF-4e and Prognosis

Oncology Reports
MedicineCancer ResearchOncology
1994English

Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas

Iranian Journal of Pathology
Forensic MedicinePathology
2020English

Immunohistochemical Study on P53 Expression in Hepatocellular Carcinomas.

Acta Hepatologica Japonica
Hepatology
1993English

The Prognosis of Stage IA Synchronous Endometrial Endometrioid and Ovarian Carcinomas

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2019English

Over-Expression of Cathepsin B in Hepatocellular Carcinomas Predicts Poor Prognosis of HCC Patients

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2016English

Immunohistochemical Analysis of LRIG Proteins in Meningiomas: Correlation Between Estrogen Receptor Status and LRIG Expression

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2012English

STUDY OF THE IMMUNOHISTOCHEMICAL EXPRESSION OF P53 AND Ki67 (MIB1) IN OVARIAN TUMOURS AND THEIR CORRELATION WITH CLINICOPATHOLOGICAL FACTORS

Journal of Evidence Based Medicine and Healthcare
2019English

Immunohistochemical Expression of Human Epididymis 4 in Ovarian Malignancy

International Journal of Research in Medical Sciences
2019English

Analysis of the Correlation Between P53 and Cox-2 Expression and Prognosis in Esophageal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy